Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67.75 EUR | 0.00% |
|
+0.15% | +99.26% |
Jul. 17 | Oxford Biomedica Names New Finance Chief | MT |
Jul. 17 | K3 Business sees interim revenue decline | AN |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+99.26% | 2.78B | |
+24.74% | 47.96B | |
-0.47% | 42.45B | |
+43.96% | 41.47B | |
+25.40% | 31.6B | |
+17.96% | 28.63B | |
-4.47% | 28.03B | |
+50.73% | 14.56B | |
+42.56% | 14.14B | |
+1.46% | 12.58B |
- Stock Market
- Equities
- MOR Stock
- News MorphoSys AG
- Transcript : MorphoSys AG Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-13-2023 02